1887
  1. Home
  2. Eurosurveillance
  3. Volume 20, Issue 48, 03/Dec/2015
  4. Article
Rapid communication Open Access
Like 0
Download

Abstract

infection can cause pneumonia, particularly in children. Global increase in macrolide-resistant is of concern due to limited therapeutic options. We describe the detection of macrolide resistance-conferring mutations in 9.3% of 43 clinical specimens where was detected in England and Wales from September 2014‒September 2015. This study aims to impact by highlighting the presence of macrolide resistance in positive patients, promoting increased clinical vigilance.

© Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.
Loading

Article metrics loading...

/content/10.2807/1560-7917.ES.2015.20.48.30078
2015-12-03
2024-11-04
http://instance.metastore.ingenta.com/content/10.2807/1560-7917.ES.2015.20.48.30078
Loading
Loading full text...

Full text loading...

/deliver/fulltext/eurosurveillance/20/48/eurosurv-20-48-2.html?itemId=/content/10.2807/1560-7917.ES.2015.20.48.30078&mimeType=html&fmt=ahah

References

  1. Chalker VJ, Stocki T, Mentasti M, Harnden A, Wang K, Harrison TG. Macrolide resistant Mycoplasma pneumoniae in England and Wales: Abstract P724, 22nd European Congress of Clinical Microbiology and Infectious Diseases. Clin Microbiol Infect. 2012;18(S3):135.
  2. Ferguson GD, Gadsby NJ, Henderson SS, Hardie A, Kalima P, Morris AC, et al. Clinical outcomes and macrolide resistance in Mycoplasma pneumoniae infection in Scotland, UK. J Med Microbiol. 2013;62(Pt 12):1876-82. . https://doi.org/10.1099/jmm.0.066191-0  PMID: 24008501 
  3. Li X, Atkinson TP, Hagood J, Makris C, Duffy LB, Waites KB. Emerging macrolide resistance in Mycoplasma pneumoniae in children: detection and characterization of resistant isolates. Pediatr Infect Dis J. 2009;28(8):693-6. . https://doi.org/10.1097/INF.0b013e31819e3f7a  PMID: 19633515 
  4. Wang K, Chalker V, Bermingham A, Harrison T, Mant D, Harnden A. Mycoplasma pneumoniae and respiratory virus infections in children with persistent cough in England: a retrospective analysis. Pediatr Infect Dis J. 2011;30(12):1047-51. . https://doi.org/10.1097/INF.0b013e31822db5e2  PMID: 21857262 
  5. Narita M. Pathogenesis of extrapulmonary manifestations of Mycoplasma pneumoniae infection with special reference to pneumonia. J Infect Chemother. 2010;16(3):162-9. . https://doi.org/10.1007/s10156-010-0044-X  PMID: 20186455 
  6. Bitnun A, Ford-Jones E, Blaser S, Richardson S. Mycoplasma pneumoniae ecephalitis. Semin Pediatr Infect Dis. 2003;14(2):96-107. . https://doi.org/10.1053/spid.2003.127226  PMID: 12881797 
  7. Olson D, Watkins LK, Demirjian A, Lin X, Robinson CC, Pretty K, et al. Outbreak of Mycoplasma pneumoniae-Associated Stevens-Johnson Syndrome. Pediatrics. 2015;136(2):e386-94. . https://doi.org/10.1542/peds.2015-0278  PMID: 26216320 
  8. Gu L, Chen X, Li H, Qu J, Miao M, Zhou F, et al. A case of lethal hemolytic anemia associated with severe pneumonia caused by Mycoplasma pneumoniae. Chin Med J (Engl). 2014;127(21):3839. PMID: 25382347 
  9. Chalker VJ, Stocki T, Mentasti M, Fleming D, Sadler C, Ellis J, et al. Mycoplasma pneumoniae infection in primary care investigated by real-time PCR in England and Wales. Eur J Clin Microbiol Infect Dis. 2011;30(7):915-21. . https://doi.org/10.1007/s10096-011-1176-3  PMID: 21311941 
  10. Spuesens EB, Fraaij PL, Visser EG, Hoogenboezem T, Hop WC, van Adrichem LN, et al. Carriage of Mycoplasma pneumoniae in the upper respiratory tract of symptomatic and asymptomatic children: an observational study. PLoS Med. 2013;10(5):e1001444. . https://doi.org/10.1371/journal.pmed.1001444  PMID: 23690754 
  11. Lenglet A, Herrador Z, Magiorakos AP, Leitmeyer K, Coulombier DEuropean Working Group on Mycoplasma pneumoniae surveillance. Surveillance status and recent data for Mycoplasma pneumoniae infections in the European Union and European Economic Area, January 2012. Euro Surveill. 2012;17(5):20075. PMID: 22321134 
  12. Bébéar C. Editorial commentary: infections due to macrolide-resistant Mycoplasma pneumoniae: now what? Clin Infect Dis. 2012;55(12):1650-1. . https://doi.org/10.1093/cid/cis791  PMID: 22972858 
  13. Zhao F, Liu G, Wu J, Cao B, Tao X, He L, et al. Surveillance of macrolide-resistant Mycoplasma pneumoniae in Beijing, China, from 2008 to 2012. Antimicrob Agents Chemother. 2013;57(3):1521-3. . https://doi.org/10.1128/AAC.02060-12  PMID: 23263003 
  14. Principi N, Esposito S. Macrolide-resistant Mycoplasma pneumoniae: its role in respiratory infection. J Antimicrob Chemother. 2013;68(3):506-11. . https://doi.org/10.1093/jac/dks457  PMID: 23169891 
  15. Bébéar C, Pereyre S, Peuchant O. Mycoplasma pneumoniae: susceptibility and resistance to antibiotics. Future Microbiol. 2011;6(4):423-31. . https://doi.org/10.2217/fmb.11.18  PMID: 21526943 
  16. Bébéar CM, Pereyre S. Mechanisms of drug resistance in Mycoplasma pneumoniae. Curr Drug Targets Infect Disord. 2005;5(3):263-71. . https://doi.org/10.2174/1568005054880109  PMID: 16181145 
  17. Harris M, Clark J, Coote N, Fletcher P, Harnden A, McKean M, et al. British Thoracic Society Standards of Care Committee. British Thoracic Society guidelines for the management of community acquired pneumonia in children: update 2011. Thorax. 2011;66(Suppl 2):ii1-23. . https://doi.org/10.1136/thoraxjnl-2011-200598  PMID: 21903691 
  18. Lim WS, Baudouin SV, George RC, Hill AT, Jamieson C, Le Jeune I, et al. BTS guidelines for the management of community acquired pneumonia in adults: update 2009. Thorax. 2009;64(S3):pii:1-55.
  19. Bebear C, Kempf I. Antimicrobial therapy and antimicrobial resistance. In Blanchard A, Browning G, editors. Mycoplasmas: Pathogenesis, Molecular Biology, and Emerging Strategies for Control. Horizon Bioscience: Wymondham, UK; 2005.
  20. Rao RP, Ghanayem NS, Kaufman BA, Kehl KS, Gregg DC, Chusid MJ. Mycoplasma hominis and Ureaplasma species brain abscess in a neonate. Pediatr Infect Dis J. 2002;21(11):1083-5. . https://doi.org/10.1097/00006454-200211000-00026  PMID: 12458575 
  21. Bradley JS, Byington CL, Shah SS, Alverson B, Carter ER, Harrison C, et al. Pediatric Infectious Diseases Society and the Infectious Diseases Society of America. The management of community-acquired pneumonia in infants and children older than 3 months of age: clinical practice guidelines by the Pediatric Infectious Diseases Society and the Infectious Diseases Society of America. Clin Infect Dis. 2011;53(7):e25-76. . https://doi.org/10.1093/cid/cir531  PMID: 21880587 
  22. Cardinale F, Chironna M, Dumke R, Binetti A, Daleno C, Sallustio A, et al. Macrolide-resistant Mycoplasma pneumoniae in paediatric pneumonia. Eur Respir J. 2011;37(6):1522-4. . https://doi.org/10.1183/09031936.00172510  PMID: 21632830 
Detection of macrolide resistant Mycoplasma pneumoniae in England, September 2014 to September 2015
<p class="citation"> <span>Citation style for this article:</span> <span class="meta-value authors"> <a href="/search?value1=Rebecca+J+Brown&option1=author&noRedirect=true" class="nonDisambigAuthorLink">Brown Rebecca J</a>, <a href="/search?value1=Louissa+Macfarlane-Smith&option1=author&noRedirect=true" class="nonDisambigAuthorLink">Macfarlane-Smith Louissa</a>, <a href="/search?value1=Sarah+Phillips&option1=author&noRedirect=true" class="nonDisambigAuthorLink">Phillips Sarah</a>, <a href="/search?value1=Victoria+J+Chalker&option1=author&noRedirect=true" class="nonDisambigAuthorLink">Chalker Victoria J</a></span>. Detection of macrolide resistant Mycoplasma pneumoniae in England, September 2014 to September 2015. <a href="/content/ecdc">Euro Surveill.</a> 2015;20(48):pii=30078. <a href="https://doi.org/10.2807/1560-7917.ES.2015.20.48.30078" title="doi link" target="_blank">https://doi.org/10.2807/1560-7917.ES.2015.20.48.30078</a> <span class="ES_Article_citation"> <span class="generated">Received</span>: 17 Nov 2015;&nbsp;&nbsp; <span class="generated">Accepted</span>: 03 Dec 2015 </span> </p>
/content/10.2807/1560-7917.ES.2015.20.48.30078
/content/10.2807/1560-7917.ES.2015.20.48.30078
Loading

Data & Media loading...

Submit comment
Close
Comment moderation successfully completed
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error